Abstract CT050: Zongertinib in patients with pretreated HER2-mutant advanced NSCLC: Beamion LUNG-1
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: John V. Heymach, Gerrina Ruiter, Myung-Ju Ahn, Nicolas Girard, Egbert Smit, David Planchard, Yi-Long Wu, Byoung Chul Cho, Noboru Yamamoto, Joshua K. Sabari, Yanqiu Zhao, Hai-Yan Tu, Kiyotaka Yoh, Ernest Nadal, Behbood Sadrolhefazi, Maren Rohrbacher, Ute von Wangenheim, Sabina Eigenbrod-Giese, Jon Zugazagoitia
Institutions: The University of Texas MD Anderson Cancer Center, The Netherlands Cancer Institute, Samsung Medical Center, Sungkyunkwan University, Université de Versailles Saint-Quentin-en-Yvelines, Institut Curie, Leiden University Medical Center, Université Paris-Saclay, Institut Gustave Roussy, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, National Cancer Center Hospital, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Zhengzhou University, Henan Cancer Hospital, National Cancer Center Hospital East, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany), Hospital Universitario 12 De Octubre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410596306